VEA
IRON icon

Virtus ETF Advisers’s Disc Medicine IRON Stock Holding History

Virtus ETF Advisers’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,106
Closed -$70.1K – 607
2024
Q4 		$70.1K Sell
1,106
-1,247
-53% -$72.1K 0.03% 378
2024
Q3 		$116K Buy
2,353
+41
+2% +$1.93K 0.05% 357
2024
Q2 		$104K Buy
2,312
+824
+55% +$28K 0.05% 331
2024
Q1 		$92.6K Sell
1,488
-101
-6% -$6.55K 0.05% 376
2023
Q4 		$91.8K Sell
1,589
-425
-21% -$21.8K 0.06% 399
2023
Q3 		$94.6K Sell
2,014
-205
-9% -$10.3K 0.06% 341
2023
Q2 		$98.5K Buy
+2,219
New +$78.7K 0.06% 391
2021
Q4 		– Sell
-623
Closed -$76K – 390
2021
Q3 		$76K Sell
623
-33
-5% -$4.51K 0.03% 390
2021
Q2 		$127K Buy
+656
New +$216K 0.05% 395

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtus ETF Advisers's IRON Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Disc Medicine (IRON) in Q1 2025, closing a stake of 1,106 shares — an estimated $70.1K sold.

Virtus ETF Advisers first reported a position in IRON in Q2 2021 and held it in 9 quarters. The position peaked at $127K in Q2 2021. 157 funds tracked by Wall St. Rank hold IRON as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Disc Medicine position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,106 Disc Medicine shares in Q1 2025, an estimated $70.1K.
  • Virtus ETF Advisers first reported a position in Disc Medicine in Q2 2021 and held it in 9 quarters.
  • Virtus ETF Advisers's Disc Medicine position peaked at $127K in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.